BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28703775)

  • 1. Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review.
    Li B; He X; Jia W; Li H
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28703775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacometabonomics - the novel way to personalized drug therapy].
    Maslov DL; Balashova EE; Lokhov PG; Archakov AI
    Biomed Khim; 2017 Mar; 63(2):115-123. PubMed ID: 28414282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in the personalized medicine using pharmacometabonomics].
    Huang Q; A JY; Zhou GH
    Yao Xue Xue Bao; 2014 Nov; 49(11):1491-7. PubMed ID: 25757272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
    Everett JR
    Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacometabonomics and personalized medicine.
    Everett JR; Loo RL; Pullen FS
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics and Personalized Medicine.
    Koen N; Du Preez I; Loots du T
    Adv Protein Chem Struct Biol; 2016; 102():53-78. PubMed ID: 26827602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine.
    Everett JR
    Front Pharmacol; 2016; 7():297. PubMed ID: 27660611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacometabonomics: data processing and statistical analysis.
    Fu J; Zhang Y; Liu J; Lian X; Tang J; Zhu F
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33866355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
    Frédérich M; Pirotte B; Fillet M; de Tullio P
    J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized medicine into health national services: barriers and potentialities.
    Rodríguez Vicente AE; Herrero Cervera MJ; Bernal ML; Rojas L; Peiró AM
    Drug Metab Pers Ther; 2018 Dec; 33(4):159-163. PubMed ID: 30391933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics as a tool for drug discovery and personalised medicine. A review.
    Mastrangelo A; Armitage EG; García A; Barbas C
    Curr Top Med Chem; 2014; 14(23):2627-36. PubMed ID: 25515755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics in Cardiovascular Medicine.
    Weeke PE
    Adv Pharmacol; 2018; 83():333-360. PubMed ID: 29801582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
    Valdes R; Yin DT
    Clin Lab Med; 2016 Sep; 36(3):447-59. PubMed ID: 27514461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
    Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
    Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of Treatment.
    Katsila T; Patrinos GP
    Curr Pharm Des; 2017; 23(14):2027. PubMed ID: 28701139
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.